Managing drug shortages during a pandemic: tocilizumab and COVID-19

Overview of attention for article published in Canadian Medical Association Journal, May 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

news: 8 news outlets
blogs: 1 blog
policy: 2 policy sources

twitter: 21 X users
facebook: 1 Facebook page

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 54 Mendeley

Summary News Blogs Policy documents X Facebook Dimensions citations

So far, Altmetric has seen 12 news stories from 8 outlets.

Roche Canada Announces Purchase Agreement with the Government of Canada for ACTEMRA® IV (tocilizumab for injection) for Treatment of Adult Patients with COVID-19

Ticker Tech, 01 Dec 2022

MISSISSAUGA, ON, Dec. 1, 2022 /CNW/ - Hoffmann-La Roche Limited (Roche Canada) announced today that it has signed agreements…

Roche Canada Announces Purchase Agreement with the Government of Canada for ACTEMRA® IV (tocilizumab for injection) for Treatment of Adult Patients with COVID-19

Yahoo! Finance USA, 01 Dec 2022

MISSISSAUGA, ON, Dec. 1, 2022 /CNW/ - Hoffmann-La Roche Limited (Roche Canada) announced today that it has signed agreements…

Roche Canada Announces Purchase Agreement with the Government of Canada for ACTEMRA® IV (tocilizumab for injection) for Treatment of Adult Patients with COVID-19

Benzinga, 01 Dec 2022

MISSISSAUGA, ON, Dec. 1, 2022 /CNW/ - Hoffmann-La Roche Limited (Roche Canada) announced today that it has signed agreements…

Roche Canada Announces Purchase Agreement with the Government of Canada for ACTEMRA IV (tocilizumab for injection) for Treatment of Adult Patients with COVID-19

Biospace, 01 Dec 2022

MISSISSAUGA, ON, Dec. 1, 2022 /CNW/ - Hoffmann-La Roche Limited (Roche Canada) announced today that it has signed agreements…

ACTEMRA® IV (tocilizumab for injection) Receives Authorization for Additional Indication from Health Canada for the Treatment of COVID-19

Spoke, 28 Oct 2022

ACTEMRA is shown to improve outcomes including mortality in patients hospitalized with COVID-19 requiring supplemental oxygen.1…

ACTEMRA® IV (tocilizumab for injection) Receives Authorization for Additional Indication from Health Canada for the Treatment of COVID-19

Ticker Tech, 28 Oct 2022

MISSISSAUGA, ON, Oct. 28, 2022 /CNW/ - Hoffmann-La Roche Limited (Roche Canada) is pleased to announce that on October 13, 2022…

ACTEMRA® IV (tocilizumab for injection) Receives Authorization for Additional Indication from Health Canada for the Treatment of COVID-19

Yahoo! Finance USA, 28 Oct 2022

ACTEMRA is shown to improve outcomes including mortality in patients hospitalized with COVID-19 requiring supplemental oxygen.1…

ACTEMRA® IV (tocilizumab for injection) Receives Authorization for Additional Indication from Health Canada for the Treatment of COVID-19

Yahoo!, 28 Oct 2022

MISSISSAUGA, ON, Oct. 28, 2022 /CNW/ - Hoffmann-La Roche Limited (Roche Canada) is pleased to announce that on October 13, 2022…

ACTEMRA® IV (tocilizumab for injection) Receives Authorization for Additional Indication from Health Canada for the Treatment of COVID-19

Benzinga, 28 Oct 2022

ACTEMRA is shown to improve outcomes including mortality in patients hospitalized with COVID-19 requiring supplemental oxygen.1…

ACTEMRA IV (tocilizumab for injection) Receives Authorization for Additional Indication from Health Canada for the Treatment of COVID-19

Biospace, 28 Oct 2022

ACTEMRA is shown to improve outcomes including mortality in patients hospitalized with COVID-19 requiring supplemental oxygen.1…

Analysis spotlights shortage of a COVID-19 drug in Canada

Centre for Disease Research and Policy, 06 May 2021

Tocilizumab, like other potential COVID-19 drug treatments, is in spot shortages around the world.

Better response to drug shortages could be an important legacy of COVID-19

The Toronto Star, 05 May 2021

COVID-19 is currently the most common reason people are hospitalized in Ontario and there only two medications that can reduce…

CMAJ

Article Metrics

Managing drug shortages during a pandemic: tocilizumab and COVID-19

About this Attention Score

Mentioned by

Citations

Readers on

Roche Canada Announces Purchase Agreement with the Government of Canada for ACTEMRA® IV (tocilizumab for injection) for Treatment of Adult Patients with COVID-19

Ticker Tech, 01 Dec 2022

Roche Canada Announces Purchase Agreement with the Government of Canada for ACTEMRA® IV (tocilizumab for injection) for Treatment of Adult Patients with COVID-19

Yahoo! Finance USA, 01 Dec 2022

Roche Canada Announces Purchase Agreement with the Government of Canada for ACTEMRA® IV (tocilizumab for injection) for Treatment of Adult Patients with COVID-19

Benzinga, 01 Dec 2022

Roche Canada Announces Purchase Agreement with the Government of Canada for ACTEMRA IV (tocilizumab for injection) for Treatment of Adult Patients with COVID-19

Biospace, 01 Dec 2022

ACTEMRA® IV (tocilizumab for injection) Receives Authorization for Additional Indication from Health Canada for the Treatment of COVID-19

Spoke, 28 Oct 2022

ACTEMRA® IV (tocilizumab for injection) Receives Authorization for Additional Indication from Health Canada for the Treatment of COVID-19

Ticker Tech, 28 Oct 2022

ACTEMRA® IV (tocilizumab for injection) Receives Authorization for Additional Indication from Health Canada for the Treatment of COVID-19

Yahoo! Finance USA, 28 Oct 2022

ACTEMRA® IV (tocilizumab for injection) Receives Authorization for Additional Indication from Health Canada for the Treatment of COVID-19

Yahoo!, 28 Oct 2022

ACTEMRA® IV (tocilizumab for injection) Receives Authorization for Additional Indication from Health Canada for the Treatment of COVID-19

Benzinga, 28 Oct 2022

ACTEMRA IV (tocilizumab for injection) Receives Authorization for Additional Indication from Health Canada for the Treatment of COVID-19

Biospace, 28 Oct 2022

Analysis spotlights shortage of a COVID-19 drug in Canada

Centre for Disease Research and Policy, 06 May 2021

Better response to drug shortages could be an important legacy of COVID-19

The Toronto Star, 05 May 2021